BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 31744889)

  • 81. Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study.
    Salvo G; Ramirez PT; Leitao MM; Cibula D; Wu X; Falconer H; Persson J; Perrotta M; Mosgaard BJ; Kucukmetin A; Berlev I; Rendon G; Liu K; Vieira M; Capilna ME; Fotopoulou C; Baiocchi G; Kaidarova D; Ribeiro R; Pedra-Nobre S; Kocian R; Li X; Li J; Pálsdóttir K; Noll F; Rundle S; Ulrikh E; Hu Z; Gheorghe M; Saso S; Bolatbekova R; Tsunoda A; Pitcher B; Wu J; Urbauer D; Pareja R
    Am J Obstet Gynecol; 2022 Jan; 226(1):97.e1-97.e16. PubMed ID: 34461074
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
    Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
    J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Surgical and Oncologic Outcomes of Radical Abdominal Trachelectomy Versus Hysterectomy for Stage IA2-IB1 Cervical Cancer.
    Guo J; Zhang Y; Chen X; Sun L; Chen K; Sheng X
    J Minim Invasive Gynecol; 2019; 26(3):484-491. PubMed ID: 29908338
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Patient-tailored conservative surgical treatment of invasive uterine cervical squamous cell carcinoma. A review.
    Menczer J
    Minerva Ginecol; 2013 Aug; 65(4):407-15. PubMed ID: 24051940
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Oncologic and obstetric outcomes of early stage cervical cancer with abdominal radical trachelectomy: Single-institution experience.
    Tamauchi S; Kajiyama H; Sakata J; Sekiya R; Suzuki S; Mizuno M; Utsumi F; Niimi K; Kotani T; Shibata K; Kikkawa F
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1796-1801. PubMed ID: 27528387
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Abnormal menstruation after radical trachelectomy and its effects on fertility.
    Matsuoka M; Taga A; Hata S; Yamamoto R; Ando Y; Kozono Y; Tsuji N; Sekiyama K; Higuchi T; Nagano T
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1906-1912. PubMed ID: 31215125
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Neo-adjuvant chemotherapy in fertility-sparing cervical cancer treatment.
    Kasius JC; van der Velden J; Denswil NP; Tromp JM; Mom CH
    Best Pract Res Clin Obstet Gynaecol; 2021 Sep; 75():82-100. PubMed ID: 33752979
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fertility-sparing surgery vs standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size.
    Jorgensen KA; Agusti N; Wu CF; Kanbergs A; Pareja R; Ramirez PT; Rauh-Hain JA; Melamed A
    Am J Obstet Gynecol; 2024 Jun; 230(6):663.e1-663.e13. PubMed ID: 38365097
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer: a single-institution experience.
    Okugawa K; Yahata H; Sonoda K; Kodama K; Yagi H; Ohgami T; Yasunaga M; Onoyama I; Kaneki E; Asanoma K; Kobayashi H; Kato K
    Int J Clin Oncol; 2021 Jan; 26(1):216-224. PubMed ID: 32880780
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Fertility-sparing surgery and fertility preservation in cervical cancer: The desire for parenthood, reproductive and obstetric outcomes.
    van der Plas RCJ; Bos AME; Jürgenliemk-Schulz IM; Gerestein CG; Zweemer RP
    Gynecol Oncol; 2021 Dec; 163(3):538-544. PubMed ID: 34583837
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer.
    Park DC; Kim JH; Lew YO; Kim DH; Namkoong SE
    Gynecol Oncol; 2004 Jan; 92(1):59-63. PubMed ID: 14751139
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer.
    Schneider A; Erdemoglu E; Chiantera V; Reed N; Morice P; Rodolakis A; Denschlag D; Kesic V
    Int J Gynecol Cancer; 2012 May; 22(4):659-66. PubMed ID: 22398708
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?
    Ju UC; Kang WD; Kim SM
    J Gynecol Oncol; 2018 Jul; 29(4):e54. PubMed ID: 29770624
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 98. Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study.
    Benedetti Panici P; Palaia I; Marchetti C; Ruscito I; Fischetti M; Musella A; Di Donato V; Perniola G; Vertechy L; Muzii L
    Oncology; 2015; 89(2):103-10. PubMed ID: 25924602
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Fertility-sparing surgery for uterine cervical cancer.
    Sato S; Itamochi H; Sugiyama T
    Future Oncol; 2016 Oct; 12(20):2345-55. PubMed ID: 27578750
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Neoadjuvant chemotherapy in bulky stage IB-IIA cervical cancer: results of a quick course with vincristine, bleomycin, and cisplatin.
    Ki KD; Song DH; Tong SY; Lim MC; Lee JM; Lee SK
    Int J Gynecol Cancer; 2009 Jan; 19(1):50-3. PubMed ID: 19258941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.